ALB and breast cancer: Considering the world’s growing interest in natural health-promoting actives, the current study explored, for the first time, the combinatorial potential of Sambucus nigra and albumin-decorated–nanostructured lipid carriers as a new sustainable platform to support antitumour-targeted potential, particularly for the synergistic therapy of colon, ovarian, and/or breast cancer.